These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 27249595

  • 1. Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis.
    Chen Y, Ren YL, Li N, Yi XF, Wang HY.
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1974-85. PubMed ID: 27249595
    [Abstract] [Full Text] [Related]

  • 2. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review.
    Huang GQ, Xi YY, Zhang CJ, Jiang X.
    Genet Test Mol Biomarkers; 2019 Aug; 23(8):580-588. PubMed ID: 31373853
    [Abstract] [Full Text] [Related]

  • 3. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
    Li F, Tie R, Chang K, Wang F, Deng S, Lu W, Yu L, Chen M.
    BMC Cancer; 2012 Jun 19; 12():258. PubMed ID: 22712526
    [Abstract] [Full Text] [Related]

  • 4. Comparison of serum human epididymis protein 4 and CA125 on endometrial cancer detection: A meta-analysis.
    Li J, Wang X, Qu W, Wang J, Jiang SW.
    Clin Chim Acta; 2019 Jan 19; 488():215-220. PubMed ID: 30414437
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Serum Human Epididymis Protein 4 and Carbohydrate Antigen 125 as Markers in Endometrial Cancer: A Meta-Analysis.
    Hu L, Du S, Guo W, Chen D, Li Y.
    Int J Gynecol Cancer; 2016 Feb 19; 26(2):331-40. PubMed ID: 26807564
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
    Suri A, Perumal V, Ammalli P, Suryan V, Bansal SK.
    Sci Rep; 2021 Aug 27; 11(1):17308. PubMed ID: 34453074
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis.
    Dayyani F, Uhlig S, Colson B, Simon K, Rolny V, Morgenstern D, Schlumbrecht M.
    Int J Gynecol Cancer; 2016 Nov 27; 26(9):1586-1593. PubMed ID: 27540691
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.
    Wu Q, Bai SN, Song LY, Wu WF, Han LN.
    Medicine (Baltimore); 2023 Aug 18; 102(33):e34737. PubMed ID: 37603503
    [Abstract] [Full Text] [Related]

  • 9. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J, Sun X, Li B, Ming L.
    Technol Cancer Res Treat; 2017 Aug 18; 16(4):435-439. PubMed ID: 27562869
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CA125 and HE4: Measurement Tools for Ovarian Cancer.
    Zhao T, Hu W.
    Gynecol Obstet Invest; 2016 Aug 18; 81(5):430-5. PubMed ID: 27160726
    [Abstract] [Full Text] [Related]

  • 16. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.
    Angioli R, Plotti F, Capriglione S, Montera R, Damiani P, Ricciardi R, Aloisi A, Luvero D, Cafà EV, Dugo N, Angelucci M, Benedetti-Panici P.
    Tumour Biol; 2013 Feb 18; 34(1):571-6. PubMed ID: 23179397
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis.
    Lin JY, Qin JB, Li XY, Dong P, Yin BD.
    Asian Pac J Cancer Prev; 2012 Feb 18; 13(11):5427-32. PubMed ID: 23317195
    [Abstract] [Full Text] [Related]

  • 18. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
    Shen Y, Li L.
    Tumour Biol; 2016 Nov 18; 37(11):14765-14772. PubMed ID: 27629144
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.
    Zhen S, Bian LH, Chang LL, Gao X.
    Mol Clin Oncol; 2014 Jul 18; 2(4):559-566. PubMed ID: 24940495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.